levofloxacin has been researched along with Sarcoidosis, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, K; Ayers, GD; Baughman, RP; Bernard, GR; Crouser, ED; Culver, DA; Ding, T; Drake, WP; Green, A; James, WE; Judson, MA; Kerrigan, A; Sesay, A | 1 |
| Drake, WP; Isom, JM; Oswald-Richter, K; Richmond, BW; Shipley, GR; Worrell, JA; Yu, C | 1 |
1 trial(s) available for levofloxacin and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Levofloxacin; Male; Middle Aged; Respiratory Function Tests; Rifabutin; Sarcoidosis, Pulmonary | 2021 |
1 other study(ies) available for levofloxacin and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.
Topics: Azithromycin; Humans; Levofloxacin; NF-kappa B; Pulmonary Disease, Chronic Obstructive; Quality of Life; Sarcoidosis, Pulmonary | 2013 |